Imfinzi (durvalumab) - AstraZeneca
tremelimumab (CP-675206) - AstraZeneca, Pfizer
Vectibix (panitumumab) - Amgen, Takeda
albumin-bound paclitaxel - Generic mfg.
oxaliplatin - Generic mfg.
TheraCIM (nimotuzumab) - Daiichi Sankyo, Oncoscience, Biocon
Calsed (amrubicin) - Sumitomo Pharma, BMS
vinorelbine tartrate - Generic mfg.
bortezomib - Generic mfg.
pemetrexed - Generic mfg.
everolimus - Generic mfg.
erlotinib - Generic mfg.
Erbitux (cetuximab) - Eli Lilly, EMD Serono
Tecentriq (atezolizumab) - Roche
5-fluorouracil - Generic mfg.
Opdivo (nivolumab) - Ono Pharma, BMS
imatinib - Generic mfg.
doxorubicin hydrochloride - Generic mfg.
gemcitabine - Generic mfg.
carboplatin - Generic mfg.
Portrazza (necitumumab) - Eli Lilly, Nippon Kayaku
cytarabine - Generic mfg.
irinotecan - Generic mfg.
ifosfamide - Generic mfg.
topotecan - Generic mfg.
Aqupla (nedaplatin) - Simcere
Bavencio (avelumab) - EMD Serono, Pfizer
etoposide IV - Generic mfg.
Orplatna (satraplatin) - Yakult Honsha, Agennix, BMS
Herceptin (trastuzumab) - Roche
Avastin (bevacizumab) - Roche
fludarabine IV - Generic mfg.
onartuzumab (RG3638) - Roche
Keytruda (pembrolizumab) - Merck (MSD)
lobaplatin (D19466) - AEterna Zentaris
cisplatin - Generic mfg.
rilotumumab (AMG 102) - Amgen
Libtayo (cemiplimab) - Regeneron
Tyvyt (sintilimab) - Eli Lilly
http://www.ncbi.nlm.nih.gov/pubmed/35458666
 
Apr 24, 2022
 
Prev Next